Hepatic Diseases
Liver disease beyond MASH: fibrosis, iron, fat and biliary programmes. Content to be supplied by the pharma team.
The trial problem
[Pharma to supply.]
How we help
[Pharma to supply.]
Evidence
[Pharma to supply.]
Related capabilities
Multiorgan Biomarkers, MRCP+.
